Skip to main content
Caplight Logo









cliexa

cliexa

Private
Denver, ColoradoHealthcare & Life Scienceshttps://cliexa.com/

Last Round

Series A

Jun 1, 2026

Total Funding Raised

$4.25M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

cliexa is a healthcare technology company that provides an AI-powered clinical intelligence platform for real-time data integration, patient engagement, and clinical decision support.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Medical AI, Health IoT, Patient Engagement, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringRPMclinical decision supportchronic disease managementpatient-reported outcomesdigital healthhealth techEMR integrationEHR integrationAI scribeambient documentationclinical intelligencemedical AIrevenue cycle optimizationhealthcare SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

cliexa Comparables

Compare cliexa with similar companies based on industry and business-model similarity.

cliexa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KangarooHealth
83%
CareSimple
82%
HealthArc
80%

cliexa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 1, 2026
Seed RoundFeb 26, 2026
SeedFeb 25, 2025
AcceleratorMar 24, 2022
GrantMay 21, 2020
Grant
Oct 7, 2019

Key People

Founding team and executive leadership

Mehmet Kazgan

Founder, CEO

Founding Team

cliexa Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 398% MoM, reaching 11.8K.

  • Jun 1, 2026

    $10M round completed.

Recent news

Latest coverage and updates

  • partners_withJun 15, 2026

    cliexa, Inc. partnered with OpiSafe on Jun 15th '26.

cliexa Filings

Explore SEC and related filing metadata, where available.

cliexa filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about cliexa's valuation, stock price, and market status.

Is cliexa a public or private company?

cliexa is a private company.

What is the current stock price of cliexa?

cliexa is a private company with no public stock price. No recent secondary market data is available.

How much is cliexa worth (valuation)?

Valuation information for cliexa is not publicly available.

Can I buy cliexa stock?

cliexa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was cliexa's last funding round?

cliexa's most recent funding round was Seed Round on February 26, 2026.

Who are the main investors in cliexa?

Key investors in cliexa include U.S. Department of Health and Human Services, American College of Cardiology Foundation, StartUp Health.

Will cliexa IPO soon?

No public IPO plans have been announced for cliexa.

How can I track cliexa secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor cliexa's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range18
Year Founded2016
Last FundingJun 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?